Presentations at MPN Congress and ASH Annual Meeting Reinfor

New real-world evidence and application of cutting-edge AI technology underscore PharmaEssentia commitment to improving outcomes for MPN patients

...

Related Keywords

United States , San Diego , California , Canada , Taiwan , China , Taipei , T Ai Pei , Japan , South Korea , American , Taiwanese , Pharmaessentia Tpex , Raymond Urbanski , Pharmaessentia Corporation , Pharmaessentia Corporation Tpex , American Society Of Hematology , Congress Abstract Details , International Congress On Myeloproliferative Neoplasms , Affairs At Pharmaessentia , Us Head Of Clinical Development , Research Foundation , Pharmaessentia United States Corporation , Linkedin , European Medicines Agency , International Congress , Myeloproliferative Neoplasms , American Society , Annual Meeting , Chart Review , Senior Vice President , Clinical Development , Medical Affairs , North American , New Data , Pharmaessentia United States , Polycythemia Vera , Essential Thrombocythemia , Prescribing Information , Private Securities Litigation Reform Act , Markets ,